PMID: 7536934Apr 11, 1995Paper

Lipocortin 1 mediates the inhibition by dexamethasone of the induction by endotoxin of nitric oxide synthase in the rat

Proceedings of the National Academy of Sciences of the United States of America
C C WuJ R Vane

Abstract

Administration of Escherichia coli lipopolysaccharide (LPS; 10 mg/kg i.v.) to male Wistar rats caused within 240 min (i) a sustained fall (approximately 30 mmHg) in mean arterial blood pressure, (ii) a reduction (> 75%) in the pressor responses to norepinephrine (1 microgram/kg i.v.), and (iii) an induction of nitric oxide synthase (iNOS) as measured in the lung. Dexamethasone (1 mg/kg i.p. at 2 h prior to LPS) attenuated the hypotension and the vascular hyporeactivity to norepinephrine and reduced (by approximately 77%) the expression of iNOS in the lung. These effects of dexamethasone were prevented by pretreatment of LPS-treated rats with a neutralizing antiserum to lipocortin 1 (anti-LC1; 60 mg/kg s.c. at 24 h prior to LPS) but not by a control nonimmune sheep serum. Stimulation of J774.2 macrophages with LPS (1 microgram/ml for 24 h) caused the expression of iNOS and cyclooxygenase 2 (COX-2) protein and significantly increased nitrite generation; this was prevented by dexamethasone (0.1 microM at 1 h prior to LPS), which also increased cell surface lipocortin 1. Pretreatment of J774.2 cells with anti-LC1 (1:60 dilution at 4 h prior to LPS) also abolished the inhibitory effect of dexamethasone on iNOS expression and nitrite...Continue Reading

References

Jan 1, 1992·Cardiovascular Research·C E WrightS Moncada
Apr 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·J D Croxtall, R J Flower
May 29, 1992·Biochemical and Biophysical Research Communications·R A Pittner, J A Spitzer
Nov 15, 1990·Biochemical and Biophysical Research Communications·M Di RosaS Moncada
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M W RadomskiS Moncada
Aug 1, 1991·The Journal of Experimental Medicine·J K ReltonN J Rothwell
Jul 1, 1990·The Journal of Cell Biology·D D Schlaepfer, H T Haigler
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R G KilbournR F Lodato
May 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·G CirinoR B Pepinsky
Aug 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·D SalveminiJ R Vane
Dec 30, 1993·The New England Journal of Medicine·S Moncada, A Higgs
Apr 29, 1994·Biochemical and Biophysical Research Communications·Y NunokawaS Tanaka
Oct 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C J LowensteinW J Murphy
Jul 29, 1994·Biochemical and Biophysical Research Communications·S P NewmanJ D Croxtall
Mar 15, 1994·Biochemical Pharmacology·M Perretti
Mar 1, 1994·Trends in Pharmacological Sciences·R J Flower, N J Rothwell

❮ Previous
Next ❯

Citations

Jul 14, 1999·Arthritis and Rheumatism·Y YangE F Morand
Sep 26, 1997·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·C Y LiY A Ding
Aug 18, 2009·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Lei-Ming XuDu-Yun Ye
May 1, 1996·Pharmacology, Biochemistry, and Behavior·J C BuckinghamJ G Philip
Feb 15, 2003·European Journal of Pharmacology·Rebecca H RitchieGregory J Dusting
Aug 1, 1997·General Pharmacology·C Thiemermann
Aug 30, 2003·International Immunopharmacology·Viviana FerlazzoLuca Parente
Sep 6, 2000·The Biochemical Journal·C C McCormickM Calero
Feb 24, 1998·Clinical and Experimental Immunology·I HuitingaF J Tilders
Feb 13, 2001·Clinical and Experimental Immunology·G H AllcockM Perretti
Jan 13, 2000·Proceedings of the Society for Experimental Biology and Medicine·A J Spanier, K H McDonough
Mar 7, 2000·Mediators of Inflammation·H S EuzgerM Perretti
Oct 9, 2004·Inflammatory Bowel Diseases·Nathalie VergnolleChristine Coméra
Sep 3, 2004·Critical Care Medicine·Steven M HollenbergSergio Zanotti-Cavazzoni
Apr 24, 2008·Critical Care Medicine·Cheng-Ming TsaoChin-Chen Wu
Mar 1, 1996·British Journal of Pharmacology·M PerrettiR J Flower
Mar 31, 1998·Environmental Health Perspectives·L T FrameJ E Leakey
Oct 31, 2001·Neuropharmacology·W T HuangM T Lin
May 26, 2012·Pharmacology & Therapeutics·M J Paul-ClarkJ A Mitchell
Jun 15, 2011·European Journal of Pharmacology·Ching-Cheng HouMao-Tsun Lin
May 28, 2005·The American Journal of Pathology·Amilcar S DamazoMauro Perretti
Jun 16, 2004·British Journal of Pharmacology·Simon YonaRoderick J Flower
Apr 25, 2006·British Journal of Pharmacology·Simon YonaRoderick J Flower
Jan 1, 2005·Prostaglandins, Leukotrienes, and Essential Fatty Acids·S YonaR J Flower

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.